The efficacy and safety formoterol-HFA pMDI in school children with persistent asthma

A. Kamenov, S. Kamenov, B. Kamenov (Nis, Serbia And Montenegro)

Source: Annual Congress 2007 - Anti-inflammatory therapy for childhood asthma
Session: Anti-inflammatory therapy for childhood asthma
Session type: Electronic Poster Discussion
Number: 2712
Disease area: Airway diseases, Paediatric lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Kamenov, S. Kamenov, B. Kamenov (Nis, Serbia And Montenegro). The efficacy and safety formoterol-HFA pMDI in school children with persistent asthma. Eur Respir J 2007; 30: Suppl. 51, 2712

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Impact of spacer use on the efficacy and safety of ciclesonide MDI in children with persistent asthma
Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues
Year: 2009

Safety and efficacy of momethason furoate for usage in school children with mild to moderate persistent asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 290s
Year: 2003

Efficacy, safety and acceptance of salbutamol administered via MAGhaler in children with mild to moderate asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 430s
Year: 2002

Formoterol-HFA pMDI is effective and well tolerated in children with persistent asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 712s
Year: 2006

Clinical disposition, safety and efficacy of fluticasone propionate (FP) in pre-school children with persistent wheeze and asthma-like symptoms
Source: Eur Respir J 2002; 20: Suppl. 38, 219s
Year: 2002

The clinical effectiveness of HFA-beclomethasone dipropionate in children with moderate asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 166s
Year: 2004

Efficacy, safety and cost of using beclomethason dipropionate in patients with persistent moderate bronchial asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 124s
Year: 2004

The effectiveness of seretide in children with bronchial asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 125s
Year: 2004

Efficacy and tolerability of formoterol Turbuhaler in 6–11 year old children with asthma, not adequately controlled with inhaled corticosteroids
Source: Eur Respir J 2002; 20: Suppl. 38, 430s
Year: 2002

Comparison of efficacy and safety of Obucort Swinghaler with Pulmicot Turbuhaler in mild to moderate severe asthma patients
Source: Annual Congress 2010 - Drug delivery and pharmacokinetics I
Year: 2010

Ciclesonide and fluticasone propionate show comparable efficacy in children and adolescents with asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 346s
Year: 2004

Safety of formoterol in children and adolescents: experience from asthma clinical trials
Source: Annual Congress 2008 - Drug therapy and assessment of control in childhood asthma
Year: 2008


Real-life effectiveness of beclomethasone diproprionate/formoterol extra-fine combination in adult patients with persistent asthma
Source: Annual Congress 2011 - Asthma management and response
Year: 2011

Effect of fluticasone and montelukast in school children with asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 459s
Year: 2007

A post-marketing study to evaluate the safety and tolerability of a non-chlorofluorocarbon salbutamol inhaler in asthmatic patients in general practice
Source: Eur Respir J 2002; 20: Suppl. 38, 78s
Year: 2002

A comparison between the use of aerochamber with mask and nebulized budesonide respules in young preschool children: effects on health outcome and parent satisfaction
Source: Eur Respir J 2002; 20: Suppl. 38, 430s
Year: 2002

Effectiveness and safety of fluticasone propionate/salmeterol 250/50mcg administered once daily to patients with persistent asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 309s
Year: 2004

Efficacy and safety of new formulation of fluticasone propionate/salmeterol delivered via a HFA pMDI inhaler in patients with asthma
Source: Virtual Congress 2020 – Asthma inhalers: devices and adherence studies
Year: 2020


Once daily ciclesonide delivered via pMDI is effective and safe for the treatment of mild-to-moderate persistent asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 208s
Year: 2006

Formoterol as relief medication in asthma: a worldwide safety and effectiveness trial
Source: Eur Respir J 2003; 22: 787-794
Year: 2003